Inhibition of complement pathway activation with Pozelimab,...

Inhibition of complement pathway activation with Pozelimab, a fully human antibody to complement component C5

Latuszek, Adrianna, Liu, Yashu, Olsen, Olav, Foster, Randi, Cao, Marc, Lovric, Irena, Yuan, Ming, Liu, Nina, Chen, Henry, Zhang, Qian, Xiao, Hui, Springer, Carola, Ehrlich, George, Kamat, Vishal, Rafi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0231892
Date:
May, 2020
File:
PDF, 1.64 MB
2020
Conversion to is in progress
Conversion to is failed